To include your compound in the COVID-19 Resource Center, submit it here.

MediGene, Wolf Research Pharmaceutical GmbH deal

MDG gained additional rights from Wolf to Etomoxir, a

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE